Pages that link to "Item:Q903295"
From MaRDI portal
The following pages link to Approximate dynamic programming and its applications to the design of Phase I cancer trials (Q903295):
Displaying 14 items.
- Optimal designs for contingent response models with application to toxicity-efficacy studies (Q389259) (← links)
- Information in a two-stage adaptive optimal design (Q389442) (← links)
- The treatment versus experimentation dilemma in dose finding studies (Q538132) (← links)
- A new characterization of Elfving's method for high dimensional computation (Q665037) (← links)
- Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
- Optimal sequential designs in phase I studies (Q1621308) (← links)
- Approximating the operating characteristics of Bayesian uncertainty directed trial designs (Q2156810) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Control Theory and Experimental Design in Diffusion Processes (Q2945147) (← links)
- A Bayesian adaptive dose-finding algorithm for balancing individual- and population-level ethics in Phase I clinical trials (Q2958397) (← links)
- Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs (Q3013989) (← links)
- (Q5072154) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
- Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies (Q6629385) (← links)
